FEB 08, 2019 9:11 PM PST

Bodybuilding Supplement Harms Brain Cells

WRITTEN BY: Nouran Amin

Researchers at University of Technology Sydney warn that the protein supplement, L-norvaline, could damage brain cells. The study was published in Toxicology in Vitro describes how at low concentrations, L-norvaline induces unhealthy cells in the brain. The was the first reporting to investigate the toxicity of L-norvaline in human cells with a specific focus on the health of brain cells.

L-norvaline is a widely used bodybuilding supplement and promoted as a compound that can boost workouts and aid recovery. Naturally, our bodies use amino acids from our diet to make new proteins—however, L-norvaline is one of the amino acids that are not usually used by our physiological system to produce proteins.

Learn more about bodybuilding supplements:

"Protein requirements are higher in very active individuals and proteins are considered to improve and increase performance. The demand for amino acids in supplements has expanded but in addition to the normal protein-building amino acids other 'non-protein' amino acids are being taken," explains lead author, Kate Samardzic, a PhD candidate at UTS School of Life Sciences. "Some non-protein amino acids are toxic because they can mimic protein amino acids and deceive the body into making faulty proteins; a property used by some plants to kill predators.

Although it has been known that L-norvaline helps to produce more energy, it is now believed to damage the machinery used to generate that energy—producing long-term consequences for anyone who takes the supplement.

“Some plants can even release non-protein amino acids into the soil to kill other plants so that they can have access to all the nutrients. Chemical warfare among plants is a wellknown phenomenon. Since there was evidence that L-norvaline has an antimicrobial and herbicidal activity we examined its toxicity in human cells,” said Samardzic

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JUN 23, 2020
Drug Discovery & Development
Psychedelic DMT to Enter Clinical Trials
JUN 23, 2020
Psychedelic DMT to Enter Clinical Trials
Neuro-pharmaceutical company, MindMed, has announced that it will begin a double-blind placebo-controlled Phase 1 clinic ...
JUL 10, 2020
Drug Discovery & Development
Injection 66% Better than Daily Pill to Prevent HIV
JUL 10, 2020
Injection 66% Better than Daily Pill to Prevent HIV
Pharmaceutical company ViiV Healthcare has announced that its long-lasting, injectable drug, cabotegravir, is more effec ...
JUL 13, 2020
Cannabis Sciences
Over Half of CBD Products Falsely Labeled
JUL 13, 2020
Over Half of CBD Products Falsely Labeled
Tests conducted by the US Food and Drug Agency (FDA) have found that 55% of cannabidiol (CBD) products contain significa ...
JUL 22, 2020
Cancer
Investigating a New Target Against Esophageal Cancer
JUL 22, 2020
Investigating a New Target Against Esophageal Cancer
Esophageal cancer remains one of the most dangerous cancers in the world. Most therapies center around chemotherapy, rad ...
JUL 26, 2020
Cannabis Sciences
Medicinal Cannabis Kills Cancer Cells
JUL 26, 2020
Medicinal Cannabis Kills Cancer Cells
Researchers at the University of Newcastle have found that a modified version of medicinal cannabis can kill and inhibit ...
JUL 29, 2020
Drug Discovery & Development
Will We Have a COVID-19 Vaccine by Year-End?
JUL 29, 2020
Will We Have a COVID-19 Vaccine by Year-End?
This week, pharmaceutical companies Moderna and Pfizer launched giant Phase III 30,000-subject trials for their COVID-19 ...
Loading Comments...